Ambros, IM, Ambros, PF, Strehl, S, et al. MIC2 is a specific marker for Ewing’s sarcoma and peripheral primitive neuroectodermal tumors. Evidence for a common histogenesis of Ewing’s sarcoma and peripheral primitive neuroectodermal tumors from MIC2 expression and specific chromosome aberration. Cancer. 1991;67:1886–93.Google Scholar

Askin, FB, Rosai, J, Sibley, RK, Dehner, LP, McAlister, WH. Malignant small cell tumor of the thoracopulmonary region in childhood: a distinctive clinicopathologic entity of uncertain histogenesis. Cancer. 1979;43:2438–51.Google Scholar

Aurias, A, Rimbaut, C, Buffe, D, Zucker, JM, Mazabraud, A. Translocation involving chromosome 22 in Ewing’s sarcoma. A cytogenetic study of four fresh tumors. Cancer Genet Cytogenet. 1984;12:21–5.CrossRefGoogle ScholarPubMed

Charville, GW, Wang, WL, Ingram, DR, et al. EWSR1 fusion proteins mediate PAX7 expression in Ewing sarcoma. Mod Pathol. 2017;30:1312–20.Google Scholar

Chen, S, Deniz, K, Sung, YS, et al. Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH. Genes Chromosomes Cancer. 2016;55:340–9.CrossRefGoogle ScholarPubMed

de Alava, E, Antonescu, CR, Panizo, A, et al. Prognostic impact of P53 status in Ewing sarcoma. Cancer. 2000;15;89:783–92.Google Scholar

de Alava, E, Kawai, A, Healey, JH, et al. EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing’s sarcoma. J Clin Oncol. 1998;16:1248–55.CrossRefGoogle ScholarPubMed

Dedeurwaerdere, F, Giannini, C, Sciot, R, et al. Primary peripheral PNET/Ewing’s sarcoma of the dura: a clinicopathologic entity distinct from central PNET. Mod Pathol. 200;15:673–8.Google Scholar

Dehner, LP. Primitive neuroectodermal tumor and Ewing’s sarcoma. Am J Surg Pathol. 1993;17:1–13.CrossRefGoogle ScholarPubMed

Delattre, O, Zucman, J, Melot, T, et al. The Ewing family of tumors – a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med. 1994;331:294–9.Google Scholar

Delattre, O, Zucman, J, Plougastel, B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature. 1992;10(359):162–5.Google Scholar

Folpe, AL, Goldblum, JR, Rubin, BP, et al. Morphologic and immunophenotypic diversity in Ewing family tumors: a study of 66 genetically confirmed cases. Am J Surg Pathol. 2005;29:1025–33.Google Scholar

Folpe, AL, Hill, CE, Parham, DM, O’Shea, PA, Weiss, SW. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing’s sarcoma/primitive neuroectodermal tumor. Am J Surg Pathol. 2000;24:1657–62.Google Scholar

Hasegawa, SL, Davison, JM, Rutten, A, Fletcher, JA, Fletcher, CD. Primary cutaneous Ewing’s sarcoma: immunophenotypic and molecular cytogenetic evaluation of five cases. Am J Surg Pathol. 1998;22:310–18.Google Scholar

Hung, YP, Lee, JP, Bellizzi, AM, Hornick, JL. PHOX2B reliably distinguishes neuroblastoma among small round blue cell tumours. Histopathology. 2017;71:786–94.Google Scholar

Jeon, IS, Davis, JN, Braun, BS, et al. A variant Ewing’s sarcoma translocation (7;22) fuses the EWS gene to the ETS gene ETV1. Oncogene. 1995;10:1229–34.Google Scholar

Jimenez, RE, Folpe, AL, Lapham, RL, et al. Primary Ewing’s sarcoma/primitive neuroectodermal tumor of the kidney: a clinicopathologic and immunohistochemical analysis of 11 cases. Am J Surg Pathol. 2002;26:320–7.Google Scholar

Kawamura-Saito, M, Yamazaki, Y, Kaneko, K, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet. 2006;15:2125–37.Google Scholar

Le Deley, MC, Delattre, O, Schaefer, KL, et al. Impact of EWS-ETS fusion type on disease progression in Ewing’s sarcoma/peripheral primitive neuroectodermal tumor: prospective results from the cooperative Euro-E.W.I.N.G. 99 trial. J Clin Oncol. 2010;20:1982–8.Google Scholar

Le Loarer, F, Pissaloux, D, Coindre, JM, Tirode, F, Vince, DR. Update on families of round cell sarcomas other than classical Ewing sarcomas. Surg Pathol Clin. 2017;10:587–620.Google Scholar

Lessnick, SL, Dei Tos, AP, Sorensen, PH, et al. Small round cell sarcomas. Semin Oncol. 2009;36:338–46.Google Scholar

Miettinen, M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and Merkel cell carcinomas. Mod Pathol. 1995;8:384–8.Google Scholar

Moll, R, Löwe, A, Laufer, J, Franke, WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992;140:427–47.Google Scholar

Nicholson, SA, McDermott, MB, Swanson, PE, Wick, MR. CD99 and cytokeratin-20 in small-cell and basaloid tumors of the skin. Appl Immunohistochem Mol Morphol. 2000;8:37–41.Google Scholar

Parham, DM, Hijazi, Y, Steinberg, SM, et al. Neuroectodermal differentiation in Ewing’s sarcoma family of tumors does not predict tumor behavior. Hum Pathol. 1999;30:911–18.Google Scholar

Peter, M, Couturier, J, Pacquement, H, et al. A new member of the ETS family fused to EWS in Ewing tumors. Oncogene. 1997;13(14):1159–64.Google Scholar

Righi, A, Gambarotti, M, Longo, S, et al. Small cell osteosarcoma: clinicopathologic, immunohistochemical, and molecular analysis of 36 cases. Am J Surg Pathol. 2015;39:691–9.Google Scholar

Romeo, S, Dei Tos, AP. Soft tissue tumors associated with EWSR1 translocation. Virchows Arch. 2010;456:219–34.CrossRefGoogle ScholarPubMed

Rossi, S, Orvieto, E, Furlanetto, A, et al. Utility of the immunohistochemical detection of FLI-1 expression in round cell and vascular neoplasm using a monoclonal antibody. Mod Pathol. 2004;17:547–52.Google Scholar

Schmidt, D, Herrmann, C, Jürgens, H, Harms, D. Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing’s sarcoma. A report from the Kiel Pediatric Tumor Registry. Cancer. 1991;15(68):2251–9.Google Scholar

Sorensen, PH, Lessnick, SL, Lopez-Terrada, D, et al. A second Ewing’s sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG. Nat Genet. 1994;6:146–51.CrossRefGoogle ScholarPubMed

Stout, AP. A tumor of the ulnar nerve. Proc N Y Pathol Soc. 1918;18:2–12.Google Scholar

Szuhai, K, IJszenga, M, Tanke, HJ, et al. Detection and molecular cytogenetic characterization of a novel ring chromosome in a histological variant of Ewing sarcoma. Cancer Genet Cytogenet. 2007;172:12–22.Google Scholar

Terrier, P, Henry-Amar, M, Triche, TJ, et al. Is neuro-ectodermal differentiation of Ewing’s sarcoma of bone associated with an unfavourable prognosis? Eur J Cancer. 1995;31A:307–14.Google Scholar

Thorner, P, Squire, J, Chilton-MacNeil, S, et al. Is the EWS/FLI-1 fusion transcript specific for Ewing sarcoma and peripheral primitive neuroectodermal tumor? A report of four cases showing this transcript in a wider range of tumor types. Am J Pathol. 1996;148:1125–38.Google Scholar

Urano, F, Umezawa, A, Hong, W, Kikuchi, H, Hata, J. A novel chimera gene between EWS and E1A-F, encoding the adenovirus E1A enhancer-binding protein, in extraosseous Ewing’s sarcoma. Biochem Biophys Res Commun. 1996;15(219):608–12.Google Scholar

Wei, G, Antonescu, CR, de Alava, E, et al. Prognostic impact of INK4A deletion in Ewing sarcoma. Cancer. 2000;15(89) :793–9.Google Scholar

Zogopoulos, G, Teskey, L, Sung, L, et al. Ewing sarcoma: favourable results with combined modality therapy and conservative use of radiotherapy. Pediatr Blood Cancer. 2004;43:35–9.Google Scholar

Antonescu, CR, Owosho, AA, Zhang, L, et al. Sarcomas with CIC-rearrangements are a distinct pathologic entity with aggressive outcome: a clinicopathologic and molecular study of 115 cases. Am J Surg Pathol. 2017;41:941–9.Google Scholar

Choi, EY, Thomas, DG, McHugh, JB, et al. Undifferentiated small round cell sarcoma with t(4;19)(q35;q13.1) CIC-DUX4 fusion: a novel highly aggressive soft tissue tumor with distinctive histopathology. Am J Surg Pathol. 2013;37:1379–86.Google Scholar

Graham, C, Chilton-MacNeill, S, Zielenska, M, Somers, GR. The CIC-DUX4 fusion transcript is present in a subgroup of pediatric primitive round cell sarcomas. Hum Pathol. 2012;43:180–9.Google Scholar

Hung, YP, Fletcher, CD, Hornick, JL. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics. Mod Pathol. 2016;29:1324–34.Google Scholar

Italiano, A, Sung, YS, Zhang, L, et al. High prevalence of CIC fusion with double-homeobox (DUX4) transcription factors in EWSR1-negative undifferentiated small blue round cell sarcomas. Genes Chromosomes Cancer. 2012;51:207–18.CrossRefGoogle ScholarPubMed

Kawamura-Saito, M, Yamazaki, Y, Kaneko, K, et al. Fusion between CIC and DUX4 up-regulates PEA3 family genes in Ewing-like sarcomas with t(4;19)(q35;q13) translocation. Hum Mol Genet. 2006 15:2125–37.Google Scholar

Le Guellec, S, Velasco, V, Pérot, G, et al. ETV4 is a useful marker for the diagnosis of CIC-rearranged undifferentiated round-cell sarcomas: a study of 127 cases including mimicking lesions. Mod Pathol. 2016;29:1523–31.Google Scholar

Le Loarer, F, Pissaloux, D, Coindre, JM, Tirode, F, Vince, DR. Update on families of round cell sarcomas other than classical Ewing sarcomas. Surg Pathol Clin. 2017;10:587–620.Google Scholar

Richkind, KE, Romansky, SG, Finklestein, JZ. t(4;19)(q35;q13.1): a recurrent change in primitive mesenchymal tumors? Cancer Genet Cytogenet. 1996;87:71–4.Google Scholar

Siegele, B, Roberts, J, Black, JO, et al. DUX4 immunohistochemistry is a highly sensitive and specific marker for CIC-DUX4 fusion-positive round cell tumor. Am J Surg Pathol. 2017;41:423–9.Google Scholar

Smith, SC, Buehler, D, Choi, EY, et al. CIC-DUX sarcomas demonstrate frequent MYC amplification and ETS-family transcription factor expression. Mod Pathol. 2015;28:57–68.Google Scholar

Specht, K, Sung, YS, Zhang, L, et al. Distinct transcriptional signature and immunoprofile of CIC-DUX4 fusion-positive round cell tumors compared to EWSR1-rearranged Ewing sarcomas: further evidence toward distinct pathologic entities. Genes Chromosomes Cancer. 2014;53:622–33.Google Scholar

Sugita, S, Arai, Y, Aoyama, T, et al. NUTM2A-CIC fusion small round cell sarcoma: a genetically distinct variant of CIC-rearranged sarcoma. Hum Pathol. 2017;65:225–30.Google Scholar

Sugita, S, Arai, Y, Tonooka, A, Hama, N, et al. A novel CIC-FOXO4 gene fusion in undifferentiated small round cell sarcoma: a genetically distinct variant of Ewing-like sarcoma. Am J Surg Pathol. 2014;38:1571–6.Google Scholar

Yoshida, A, Arai, Y, Kobayashi, E, et al. CIC break-apart fluorescence in-situ hybridization misses a subset of CIC-DUX4 sarcomas: a clinicopathological and molecular study. Histopathology. 2017;71:461–9.Google Scholar

Yoshimoto, T, Tanaka, M, Homme, M, et al. CIC-DUX4 induces small round cell sarcomas distinct from Ewing sarcoma. Cancer Res. 2017;77:2927–37.Google Scholar

Argani, P, Kao, YC, Zhang, L, et al. Primary renal sarcomas with BCOR-CCNB3 gene fusion: a report of 2 cases showing histologic overlap with clear cell sarcoma of kidney, suggesting further link between BCOR-related sarcomas of the kidney and soft tissues. Am J Surg Pathol. 2017;41:1702–12.Google Scholar

Chiang, S, Lee, CH, Stewart, CJR, et al. BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology. Mod Pathol. 2017;30:1251–61.Google Scholar

Cohen-Gogo, S, Cellier, C, Coindre, JM, et al. Ewing-like sarcomas with BCOR-CCNB3 fusion transcript: a clinical, radiological and pathological retrospective study from the Société Française des Cancers de L’Enfant. Pediatr Blood Cancer. 2014;61:2191–8.Google Scholar

Creytens, D. SATB2 and TLE1 Expression in BCOR-CCNB3 (Ewing-like) sarcoma, mimicking small cell osteosarcoma and poorly differentiated synovial sarcoma. Appl Immunohistochem Mol Morphol. 2017 Oct 27. [Epub ahead of print]Google Scholar

Kao, YC, Owosho, AA, Sung, YS, et al. BCOR-CCNB3 fusion positive sarcomas: a clinicopathologic and molecular analysis of 36 cases with comparison to morphologic spectrum and clinical behavior of other round cell sarcomas. Am J Surg Pathol. 2017 Oct 25. [Epub ahead of print]Google Scholar

Kao, YC, Sung, YS, Zhang, L, et al. BCOR Overexpression is a highly sensitive marker in round cell sarcomas with BCOR genetic abnormalities. Am J Surg Pathol. 2016a;40:1670–8.Google Scholar

Kao, YC, Sung, YS, Zhang, L, et al. Recurrent BCOR internal tandem duplication and YWHAE-NUTM2B fusions in soft tissue undifferentiated round cell sarcoma of infancy: overlapping genetic features with clear cell sarcoma of kidney. Am J Surg Pathol. 2016b;40:1009–20.Google Scholar

Lewis, N, Soslow, RA, Delair, DF, et al. ZC3H7B-BCOR high-grade endometrial stromal sarcomas: a report of 17 cases of a newly defined entity. Mod Pathol. 2017 Dec 1. [Epub ahead of print]Google Scholar

Ludwig, K, Alaggio, R, Zin, A, et al. BCOR-CCNB3 Undifferentiated sarcoma-does immunohistochemistry help in the identification? Pediatr Dev Pathol. 2017;20:321–9.Google Scholar

Mariño-Enriquez, A, Lauria, A, Przybyl, J, et al. BCOR internal tandem duplication in high-grade uterine sarcomas. Am J Surg Pathol. 2017 Dec 1. [Epub ahead of print]Google Scholar

Matsuyama, A, Shiba, E, Umekita, Y, et al. Clinicopathologic diversity of undifferentiated sarcoma with BCOR-CCNB3 fusion: analysis of 11 cases with a reappraisal of the utility of immunohistochemistry for BCOR and CCNB3. Am J Surg Pathol. 2017;41:1713–21.Google Scholar

Peters, TL, Kumar, V, Polikepahad, S, et al. BCOR-CCNB3 fusions are frequent in undifferentiated sarcomas of male children. Mod Pathol. 2015;28:575–86.Google Scholar

Pierron, G, Tirode, F, Lucchesi, C, et al. A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusion. Nat Genet. 2012;44:461–6.Google Scholar

Puls, F, Niblett, A, Marland, G, et al. BCOR-CCNB3 (Ewing-like) sarcoma: a clinicopathologic analysis of 10 cases, in comparison with conventional Ewing sarcoma. Am J Surg Pathol. 2014;38:1307–18.Google Scholar

Specht, K, Zhang, L, Sung, YS, et al. Novel BCOR-MAML3 and ZC3H7B-BCOR gene fusions in undifferentiated small blue round cell sarcomas. Am J Surg Pathol. 2016 Apr;40(4):433–42.Google Scholar

Wong, MK, Ng, CCY, Kuick, CH, et al. Clear cell sarcomas of the kidney are characterised by BCOR gene abnormalities, including exon 15 internal tandem duplications and BCOR-CCNB3 gene fusion. Histopathology. 2018;72:320–9.Google Scholar

Bertoni, F, Picci, P, Bacchini, P, et al. Mesenchymal chondrosarcoma of bone and soft tissues. Cancer. 1983;52:533–41.Google Scholar

Frezza, AM, Cesari, M, Baumhoer, D, et al. Mesenchymal chondrosarcoma: prognostic factors and outcome in 113 patients. A European Musculoskeletal Oncology Society study. Eur J Cancer. 2015;51:374–81.CrossRefGoogle ScholarPubMed

Guccion, JG, Font, RL, Enzinger, FM, Zimmerman, LE. Extraskeletal mesenchymal chondrosarcoma. Arch Pathol. 1973;95:336–40.Google Scholar

Hoang, MP, Suarez, PA, Donner, LR, et al. Mesenchymal chondrosarcoma: a small cell neoplasm with polyphenotypic differentiation. Int J Surg Pathol. 2000;8:291–301.Google Scholar

Jacobs, JL, Merriam, JC, Chadburn, A, et al. Mesenchymal chondrosarcoma of the orbit. Report of three new cases and review of the literature. Cancer. 1994;73:399–405.Google Scholar

Knott, PD, Gannon, FH, Thompson, LD. Mesenchymal chondrosarcoma of the sinonasal tract: a clinicopathological study of 13 cases with a review of the literature. Laryngoscope. 2003;113:783–90.Google Scholar

Nakashima, Y, Unni, KK, Shives, TC, Swee, RG, Dahlin, DC. Mesenchymal chondrosarcoma of bone and soft tissue. A review of 111 cases. Cancer. 1986;57:2444–53.Google Scholar

Naumann, S, Krallman, PA, Unni, KK, et al. Translocation der(13;21)(q10;q10) in skeletal and extraskeletal mesenchymal chondrosarcoma. Mod Pathol. 2002;15:572–6.Google Scholar

Nussbeck, W, Neureiter, D, Söder, S, Inwards, C, Aigner, T. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation. Pathology. 2004;36:230–3.Google Scholar

Suster, S, Moran, CA. Malignant cartilaginous tumors of the mediastinum: clinicopathological study of six cases presenting as extraskeletal soft tissue masses. Hum Pathol. 1997;28:588–94.Google Scholar

Tsuda, Y, Ogura, K, Hakozaki, M, et al. Mesenchymal chondrosarcoma: a Japanese Musculoskeletal Oncology Group (JMOG) study on 57 patients. J Surg Oncol. 2017;115:760–7.Google Scholar

Wang, L, Motoi, T, Khanin, R, et al. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012;51:127–39.Google Scholar

Wehrli, BM, Huang, W, De Crombrugghe, B, Ayala, AG, Czerniak, B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol. 2003;34:263–9.Google Scholar

Antonescu, CR, Gerald, WL, Magid, MS, Ladanyi, M. Molecular variants of the EWS-WT1 gene fusion in desmoplastic small round cell tumor. Diagn Mol Pathol. 1998;7:24–8.Google Scholar

Barnoud, R, Sabourin, JC, Pasquier, D, et al. Immunohistochemical expression of WT1 by desmoplastic small round cell tumor: a comparative study with other small round cell tumors. Am J Surg Pathol. 2000;24:830–6.Google Scholar

Cummings, OW, Ulbright, TM, Young, RH, et al. Desmoplastic small round cell tumors of the paratesticular region. A report of six cases. Am J Surg Pathol. 1997;21:219–25.Google Scholar

de Alava, E, Ladanyi, M, Rosai, J, Gerald, WL. Detection of chimeric transcripts in desmoplastic small round cell tumor and related developmental tumors by reverse transcriptase polymerase chain reaction. A specific diagnostic assay. Am J Pathol. 1995;147:1584–91.Google Scholar

Froberg, K, Brown, RE, Gaylord, H, Manivel, C. Intra-abdominal desmoplastic small round cell tumor: immunohistochemical evidence for up-regulation of autocrine and paracrine growth factors. Ann Clin Lab Sci. 1999;29:78–85.Google Scholar

Gerald, WL, Ladanyi, M, de Alava, E, et al. Clinical, pathologic, and molecular spectrum of tumors associated with t(11;22)(p13;q12): desmoplastic small round-cell tumor and its variants. J Clin Oncol. 1998;16:3028–36.Google Scholar

Gerald, WL, Miller, HK, Battifora, H, et al. Intra-abdominal desmoplastic small round-cell tumor. Report of 19 cases of a distinctive type of high-grade polyphenotypic malignancy affecting young individuals. Am J Surg Pathol. 1991;15:499–513.Google Scholar

Gerald, WL, Rosai, J. Case 2. Desmoplastic small cell tumor with divergent differentiation. Pediatr Pathol. 1989;9:177–83.Google Scholar

Gerald, WL, Rosai, J, Ladanyi, M. Characterization of the genomic breakpoint and chimeric transcripts in the EWS-WT1 gene fusion of desmoplastic small round cell tumor. Proc Natl Acad Sci U S A. 1995;92:1028–32.Google Scholar

Gonzalez-Crussi, F, Crawford, SE, Sun, CC. Intraabdominal desmoplastic small-cell tumors with divergent differentiation. Observations on three cases of childhood. Am J Surg Pathol. 1990;14:633–42.Google Scholar

Hill, DA, Pfeifer, JD, Marley, EF, et al. WT1 staining reliably differentiates desmoplastic small round cell tumor from Ewing sarcoma/primitive neuroectodermal tumor. An immunohistochemical and molecular diagnostic study. Am J Clin Pathol. 2000;114:345–53.Google Scholar

Kushner, BH, LaQuaglia, MP, Wollner, N, et al. Desmoplastic small round-cell tumor: prolonged progression-free survival with aggressive multimodality therapy. J Clin Oncol. 1996;14:1526–31.Google Scholar

Ladanyi, M, Gerald, W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumor. Cancer Res. 1994;54:2837–40.Google Scholar

Lae, ME, Roche, PC, Jin, L, Lloyd, RV, Nascimento, AG. Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors. Am J Surg Pathol. 2002;26:823–35.Google Scholar

Lee, SB, Kolquist, KA, Nichols, K, et al. The EWS-WT1 translocation product induces PDGFA in desmoplastic small round-cell tumour. Nat Genet. 1997;17:309–13.Google Scholar

Mohamed, M, Gonzalez, D, Fritchie, KJ, et al. Desmoplastic small round cell tumor: evaluation of reverse transcription-polymerase chain reaction and fluorescence in situ hybridization as ancillary molecular diagnostic techniques. Virchows Arch. 2017;471:631–40.Google Scholar

Mora, J, Modak, S, Cheung, NK, et al. Desmoplastic small round cell tumor 20 years after its discovery. Future Oncol. 2015;11:1071–81.Google Scholar

Ordi, J, de Alava, E, Torné, A, et al. Intraabdominal desmoplastic small round cell tumor with EWS/ERG fusion transcript. Am J Surg Pathol. 1998;22:1026–32.Google Scholar

Ordóñez, NG. Desmoplastic small round cell tumor: I: a histopathologic study of 39 cases with emphasis on unusual histological patterns. Am J Surg Pathol. 1998a;22:1303–13.Google Scholar

Ordóñez, NG. Desmoplastic small round cell tumor: II: an ultrastructural and immunohistochemical study with emphasis on new immunohistochemical markers. Am J Surg Pathol. 1998b;22:1314–27.Google Scholar

Ordóñez, NG, Zirkin, R, Bloom, RE. Malignant small-cell epithelial tumor of the peritoneum coexpressing mesenchymal-type intermediate filaments. Am J Surg Pathol. 1989;3:413–21.Google Scholar

Parkash, V, Gerald, WL, Parma, A, Miettinen, M, Rosai, J. Desmoplastic small round cell tumor of the pleura. Am J Surg Pathol. 1995;19:659–65.Google Scholar

Rachfal, AW, Luquette, MH, Brigstock, DR. Expression of connective tissue growth factor (CCN2) in desmoplastic small round cell tumour. J Clin Pathol. 2004;57:422–5.Google Scholar

Sawyer, JR, Tryka, AF, Lewis, JM. A novel reciprocal chromosome translocation t(11;22)(p13;q12) in an intraabdominal desmoplastic small round-cell tumor. Am J Surg Pathol. 1992;16:411–16.Google Scholar

Tison, V, Cerasoli, S, Morigi, F, et al. Intracranial desmoplastic small-cell tumor. Report of a case. Am J Surg Pathol. 1996;20:112–17.Google Scholar

Trupiano, JK, Machen, SK, Barr, FG, Goldblum, JR. Cytokeratin-negative desmoplastic small round cell tumor: a report of two cases emphasizing the utility of reverse transcriptase-polymerase chain reaction. Mod Pathol. 1999;12:849–53.Google Scholar

Variend, S, Gerrard, M, Norris, PD, Goepel, JR. Intra-abdominal neuroectodermal tumour of childhood with divergent differentiation. Histopathology. 1991;18:45–51.Google Scholar

Wang, LL, Perlman, EJ, Vujanic, GM, et al. Desmoplastic small round cell tumor of the kidney in childhood. Am J Surg Pathol. 2007;31:576–84.Google Scholar

Arnold, MA, Anderson, JR, Gastier-Foster, JM, et al. Histology, fusion status, and outcome in alveolar rhabdomyosarcoma with low-risk clinical features: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2016;63:634–9.Google Scholar

Bahrami, A, Gown, AM, Baird, GS, Hicks, MJ, Folpe, AL. Aberrant expression of epithelial and neuroendocrine markers in alveolar rhabdomyosarcoma: a potentially serious diagnostic pitfall. Mod Pathol. 2008;21:795–806.Google Scholar

Barr, FG, Galili, N, Holick, J, et al. Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet. 1993;3:113–17.Google Scholar

Callender, TA, Weber, RS, Janjan, N, et al. Rhabdomyosarcoma of the nose and paranasal sinuses in adults and children. Otolaryngol Head Neck Surg. 1995;112:252–7.Google Scholar

Davicioni, E, Anderson, MJ, Finckenstein, FG, et al. Molecular classification of rhabdomyosarcoma–genotypic and phenotypic determinants of diagnosis: a report from the Children’s Oncology Group. Am J Pathol. 2009;174:550–64.Google Scholar

Douglass, EC, Shapiro, DN, Valentine, M, et al. Alveolar rhabdomyosarcoma with the t(2;13): cytogenetic findings and clinicopathologic correlations. Med Pediatr Oncol. 1993;21:83–7.Google Scholar

Enterline, HT, Horn, RC Jr. Alveolar rhabdomyosarcoma; a distinctive tumor type. Am J Clin Pathol. 1958;29:356–66.Google Scholar

Enzinger, FM, Shiraki, M. Alveolar rhabdomyosarcoma. An analysis of 110 cases. Cancer. 1969;24:18–31.Google Scholar

Harms, D. Alveolar rhabdomyosarcoma: a prognostically unfavorable rhabdomyosarcoma type and its necessary distinction from embryonal rhabdomyosarcoma. Curr Top Pathol. 1995;89:273–96.Google Scholar

Kubo, T, Shimose, S, Fujimori, J, Furuta, T, Ochi, M. Prognostic value of PAX3/7-FOXO1 fusion status in alveolar rhabdomyosarcoma: systematic review and meta-analysis. Crit Rev Oncol Hematol. 2015;96:46–53.Google Scholar

Leroy, X, Petit, ML, Fayoux, P, Aubert, S, Escande, F. Aberrant diffuse expression of synaptophysin in a sinonasal alveolar rhabdomyosarcoma. Pathology. 2007;39:275–6.Google Scholar

Newton, WA Jr, Gehan, EA, Webber, BL, et al. Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification – an Intergroup Rhabdomyosarcoma Study. Cancer. 1995;76:1073–85.Google Scholar

Parham, DM, Qualman, SJ, Teot, L, et al; Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Correlation between histology and PAX/FKHR fusion status in alveolar rhabdomyosarcoma: a report from the Children’s Oncology Group. Am J Surg Pathol. 2007;31:895–901.Google Scholar

Perel, Y, Ansoborlo, S, Bernard, P, Rivel, J, Micheau, M. Alveolar rhabdomyosarcoma presenting as leukemia. J Pediatr Hematol Oncol. 1998;20:94.Google Scholar

Reid, MM, Saunders, PW, Bown, N, et al. Alveolar rhabdomyosarcoma infiltrating bone marrow at presentation: the value to diagnosis of bone marrow trephine biopsy specimens. J Clin Pathol. 1992;45:759–62.Google Scholar

Rudzinski, ER, Anderson, JR, Chi, YY, et al. Histology, fusion status, and outcome in metastatic rhabdomyosarcoma: A report from the Children’s Oncology Group. Pediatr Blood Cancer. 2017 64(12).Google Scholar

Rudzinski, ER, Anderson, JR, Hawkins, DS, et al. The World Health Organization Classification of Skeletal Muscle Tumors in Pediatric Rhabdomyosarcoma: a report from the Children’s Oncology Group. Arch Pathol Lab Med. 2015;139:1281–7.Google Scholar

Rudzinski, ER, Teot, LA, Anderson, JR, et al. Dense pattern of embryonal rhabdomyosarcoma, a lesion easily confused with alveolar rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children’s Oncology Group. Am J Clin Pathol. 2013;140:82–90.Google Scholar

Sorensen, PH, Lynch, JC, Qualman, SJ, et al. PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: a report from the children’s oncology group. J Clin Oncol. 2002;20:2672–9.Google Scholar

Stegmaier, S, Poremba, C, Schaefer, KL, et al. Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: a report from the cooperative soft tissue sarcoma study group (CWS). Pediatr Blood Cancer. 2011;57:406–14.Google Scholar

Thompson, LDR, Jo, VY, Agaimy, A, et al. Sinonasal tract alveolar rhabdomyosarcoma in adults: a clinicopathologic and immunophenotypic study of fifty-two cases with emphasis on epithelial immunoreactivity. Head Neck Pathol. 2017;1–12. [Epub ahead of print]Google Scholar

Turc-Carel, C, Lizard-Nacol, S, Justrabo, E, et al. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet. 1986;19:361–2.Google Scholar

Yasuda, T, Perry, KD, Nelson, M, et al. Alveolar rhabdomyosarcoma of the head and neck region in older adults: genetic characterization and a review of the literature. Hum Pathol. 2009;40:341–8.Google Scholar

de Silva, MV, McMahon, AD, Paterson, L, Reid, R. Identification of poorly differentiated synovial sarcoma: a comparison of clinicopathological and cytogenetic features with those of typical synovial sarcoma. Histopathology. 2003;43:220–30.Google Scholar

Fisher, C. Synovial sarcoma. Ann Diagn Pathol. 1998;2:401–21.Google Scholar

Fligman, I, Lonardo, F, Jhanwar, SC, et al. Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript. Am J Pathol. 1995;147:1592–9.Google Scholar

Folpe, AL, Schmidt, RA, Chapman, D, Gown, AM. Poorly differentiated synovial sarcoma: immunohistochemical distinction from primitive neuroectodermal tumors and high-grade malignant peripheral nerve sheath tumors. Am J Surg Pathol. 1998;22:673–82.Google Scholar

Guillou, L, Benhattar, J, Bonichon, F, et al. Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis. J Clin Oncol. 2004;22:4040–50.Google Scholar

Machen, SK, Easley, KA, Goldblum, JR. Synovial sarcoma of the extremities: a clinicopathologic study of 34 cases, including semi-quantitative analysis of spindled, epithelial, and poorly differentiated areas. Am J Surg Pathol. 1999;23:268–75.Google Scholar

Pelmus, M, Guillou, L, Hostein, I, et al. Monophasic fibrous and poorly differentiated synovial sarcoma: immunohistochemical reassessment of 60 t(X;18)(SYT-SSX)-positive cases. Am J Surg Pathol. 2002;26:1434–40.Google Scholar

van de Rijn, M, Barr, FG, Xiong, QB, et al. Poorly differentiated synovial sarcoma: an analysis of clinical, pathologic, and molecular genetic features. Am J Surg Pathol. 1999;23:106–12.Google Scholar

Antonescu, CR, Tschernyavsky, SJ, Decuseara, R, et al. Prognostic impact of P53 status, TLS-CHOP fusion transcript structure, and histological grade in myxoid liposarcoma: a molecular and clinicopathologic study of 82 cases. Clin Cancer Res. 2001;7:3977–87.Google Scholar

Dei Tos, AP, Wadden, C, Fletcher, CDM. S-100 protein staining in liposarcoma. Its diagnostic utility in the high grade myxoid (round cell) variant. Appl Immunohistochem. 1996;4:95–101.Google Scholar

de Vreeze, RS, de Jong, D, Tielen, IH, et al. Primary retroperitoneal myxoid/round cell liposarcoma is a nonexisting disease: an immunohistochemical and molecular biological analysis. Mod Pathol. 2009;22:223–31.Google Scholar

Hoffman, A, Ghadimi, MP, Demicco, EG, et al. Localized and metastatic myxoid/round cell liposarcoma: clinical and molecular observations. Cancer. 2013;119:1868–77.Google Scholar

Kilpatrick, SE, Doyon, J, Choong, PF, Sim, FH, Nascimento, AG. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases. Cancer. 1996;77:1450–8.Google Scholar

Knight, JC, Renwick, PJ, Dal Cin, P, Van den Berghe, H, Fletcher, CD. Translocation t(12;16)(q13;p11) in myxoid liposarcoma and round cell liposarcoma: molecular and cytogenetic analysis. Cancer Res. 1995;55:24–7.Google Scholar

Orvieto, E, Furlanetto, A, Laurino, L, Dei Tos, AP. Myxoid and round cell liposarcoma: a spectrum of myxoid adipocytic neoplasia. Semin Diagn Pathol. 2001;18:267–73.Google Scholar

Smith, TA, Easley, KA, Goldblum, JR. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma. Am J Surg Pathol. 1996;20:171–80.Google Scholar

Tallini, G, Akerman, M, Dal Cin, P, et al. Combined morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing, (a report from the CHAMP Group). Am J Surg Pathol. 1996;20:1047–55.Google Scholar